Clinical Trials Directory

Trials / Completed

CompletedNCT03984071

The Predictive Value of eGFR for Adverse Cardiovascular Events in Patients With STEMI

The Predictive Value of Estimated Glomerular Filtration Rate (eGFR) for Adverse Cardiovascular Events in the Hospital in Patients With ST-segment Elevation

Status
Completed
Phase
Study type
Observational
Enrollment
3 (actual)
Sponsor
Dongying Zhang · Academic / Other
Sex
All
Age
24 Years – 93 Years
Healthy volunteers
Accepted

Summary

Estimated glomerular filtration rate(eGFR) is significantly reduced in patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study is to research that the incidence of adverse cardiovascular events (MACE) in patients with ST-segment elevation myocardial infarction is significantly higher when the glomerular filtration rate below a certain value.

Detailed description

The investigators retrospectively analyzed the clinical data of 1157 patients with ST-segment elevation myocardial infarction. In-hospital adverse cardiovascular events (MACE) was defined as: cardiac arrest, cardiac rupture, malignant arrhythmia, and cardiac death. All the patients were divided into 3 groups according to the patient's estimated glomerular filtration rate(eGFR) (eGFR≥90ml/min/1.73m2; 90ml/min/1.73m2\>eGFR≥60ml/min/1.73m2; eGFR\<60ml/min /1.73m2). COX regression analysis and K-M survival curves are used to calculate the correlation between eGFR and in-hospital MACE.

Conditions

Timeline

Start date
2015-10-01
Primary completion
2018-02-28
Completion
2018-02-28
First posted
2019-06-12
Last updated
2019-06-12

Source: ClinicalTrials.gov record NCT03984071. Inclusion in this directory is not an endorsement.